Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx

One thing many pharma companies declined to include in their New Year's resolutions? Lowering the prices of expensive brand-name drugs. Within the first few days of the year, drugmakers have raised U.S. list prices on more than 400 meds, GoodRx reports.

So far in January, drugmakers have hiked the prices on 434 branded drugs by an average of 5.2%, the group reports.